-
clinical endocrinology both paediatric and adult, genetic aspects and gene discovery in endocrine diseases, animal models, stem cells, signalling and cell biology. For further information visit: http
-
supporting delivery of the strategic aims and activities of the NIHR RSS, specifically around Equality, Diversity and Inclusion. They will be the first point of contact within the Research Support Service team
-
tools. The starting salary for this role is fixed at Grade 7, Spine Point 31 (£44,480, inclusive of London Allowance). This role is an open-ended contract with a funding duration of 12 months in the first
-
, as well as from candidates with pure research backgrounds. This job will be at a grade 7 spinal point 32 (£45,622 including London Allowance). About you We are seeking expertise in product and business
-
epilepticus. You will work in the group of academic neurologist and computer scientist Dr Gregory Scott, with a team of collaborators having expertise in translational neuroscience, clinical neurology, signal
-
. If you are applying for one of these joint fellowships, we require that the principal mentor be in Imperial, but a secondary supervisor must be at ICR/CNRS. Please indicate if this is a joint fellowship by
-
supervisor must be at ICR/CNRS. Please indicate if this is a joint fellowship by ticking the appropriate ICR/CNRS tick box in the online application form. Please note that these applications will require
-
require that the principal mentor be in Imperial, but a secondary supervisor must be at ICR/CNRS. Please indicate if this is a joint fellowship by ticking the appropriate ICR/CNRS tick box in the online
-
. If you are applying for one of these joint fellowships, we require that the principal mentor be in Imperial, but a secondary supervisor must be at ICR/CNRS. Please indicate if this is a joint fellowship by
-
mark possible), research papers rated 4*, impact rated 4*, environment rated 4*(joint), Grade Point Average and Power. REF2021 rated as world-leading: 100% of our environment, 86% of our impact and 70